Literature DB >> 18755300

Activation of T lymphocytes by polysaccharide-protein complex from Lycium barbarum L.

Zhisong Chen1, Benny Kwong Huat Tan, Soh Ha Chan.   

Abstract

T lymphocytes play central roles in adaptive immunity. Lycium barbarum L. (L. barbarum), also known as wolfberry, is a Chinese herbal medicine with various biological activities, such as enhancing immunity, protecting liver damage, and reducing the side effects of chemotherapy and radiotherapy. Here, we report that polysaccharide-protein complex from L. barbarum (LBP) is able to activate T cells. LBP was isolated from L. barbarum and separated to five homogenous fractions, designated LBPF1, LBPF2, LBPF3, LBPF4, and LBPF5. We found that LBP, LBPF4, and LBPF5 significantly stimulated mouse splenocyte proliferation. The proliferation proved to be of T cells, but not B cells. Cell cycle profile analysis indicated that LBP, LBPF4, and LBPF5 markedly reduced sub-G1 cells. LBP, LBPF4, and LBPF5 could activate transcription factors NFAT and AP-1, prompt CD25 expression, and induce IL-2 and IFN-gamma gene transcription and protein secretion. LBP (i.p. or p.o.) significantly induced T cell proliferation. Our results suggest that activation of T lymphocytes by LBP may contribute to one of its immuno-enhancement functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18755300     DOI: 10.1016/j.intimp.2008.07.019

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  22 in total

1.  Sulfated modification promotes the immunomodulatory bioactivities of Lyciumbarbarum polysaccharides in vitro.

Authors:  Junmin Wang; Beilei Ge; Chunyan Du; Jingli Xue; Yuwei Zhuang; Kun Xue
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Lycium barbarum Polysaccharide Promotes Nigrostriatal Dopamine Function by Modulating PTEN/AKT/mTOR Pathway in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Murine Model of Parkinson's Disease.

Authors:  Xiaohong Wang; Lei Pang; Yanqing Zhang; Jiang Xu; Dongyi Ding; Tianli Yang; Qian Zhao; Fan Wu; Fei Li; Haiwei Meng; Duonan Yu
Journal:  Neurochem Res       Date:  2018-03-28       Impact factor: 3.996

Review 3.  A review of the anticancer and immunomodulatory effects of Lycium barbarum fruit.

Authors:  Wai-Man Tang; Enoch Chan; Ching-Yee Kwok; Yee-Ki Lee; Jian-Hong Wu; Chun-Wai Wan; Robbie Yat-Kan Chan; Peter Hoi-Fu Yu; Shun-Wan Chan
Journal:  Inflammopharmacology       Date:  2011-12-22       Impact factor: 4.473

4.  A study on four antioxidation effects of lycium barbarum polysaccharides in vitro.

Authors:  Lili Zhang; Jinxia Gu; Yanjun Chen; Lan Zhang
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-10-03

Review 5.  An evidence-based update on the pharmacological activities and possible molecular targets of Lycium barbarum polysaccharides.

Authors:  Jiang Cheng; Zhi-Wei Zhou; Hui-Ping Sheng; Lan-Jie He; Xue-Wen Fan; Zhi-Xu He; Tao Sun; Xueji Zhang; Ruan Jin Zhao; Ling Gu; Chuanhai Cao; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2014-12-17       Impact factor: 4.162

6.  Anticancer effect of Lycium barbarum polysaccharides on colon cancer cells involves G0/G1 phase arrest.

Authors:  Fang Mao; Bingxiu Xiao; Zhen Jiang; Junwei Zhao; Xia Huang; Junming Guo
Journal:  Med Oncol       Date:  2010-01-12       Impact factor: 3.064

7.  Anti-inflammatory effects of Lacto-Wolfberry in a mouse model of experimental colitis.

Authors:  David Philippe; Viral Brahmbhatt; Francis Foata; Yen Saudan; Patrick Serrant; Stephanie Blum; Jalil Benyacoub; Karine Vidal
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

8.  Application of serum pharmacology in evaluating the antitumor effect of Fuzheng Yiliu Decoction from Chinese medicine.

Authors:  Xu-zheng Chen; Zhi-yun Cao; Lian-ming Liao; Zhi-zhen Liu; Jian Du
Journal:  Chin J Integr Med       Date:  2013-11-16       Impact factor: 1.978

9.  Lycium barbarum polysaccharides attenuate cisplatin-induced hair cell loss in rat cochlear organotypic cultures.

Authors:  Quan Liu; Yanqing Li; Li Hu; Dehui Wang
Journal:  Int J Mol Sci       Date:  2011-12-06       Impact factor: 5.923

10.  Immunomodulatory effects of the botanical compound LCS101: implications for cancer treatment.

Authors:  Itzchak H Rachmut; Noah Samuels; Steven J Melnick; Cheppail Ramachandran; Yedida Sharabi; Anya Pavlovsky; Yair Maimon; Jacob Shoham
Journal:  Onco Targets Ther       Date:  2013-04-24       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.